Physician

Adel Sandouk, M.D.

According to 2025 Medicare claims, Adel Sandouk, M.D. (NPI: 1043315575) practices pulmonary disease in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is ADEL SANDOUK, M.D., INC (NPI: 1184820961; TIN: 20-8615558) and primary practice location at 91791-1069.

Sandouk's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 554 traditional Medicare patients, billed 5,037 HCPCS/CPT codes, and received $467,269 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 4,169 prescription claims across 552 beneficiaries totaling $1,050,095 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 1,707 claims. Open Payments data shows 30 records totaling $873. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $216,239 to $1,050,095. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $20,744 to $100,605.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	578	5,596	$421,964
2016	637	7,099	$526,297
2017	673	7,640	$591,927
2018	664	8,113	$620,386
2019	600	7,096	$549,912
2020	515	6,881	$582,978
2021	493	6,127	$551,120
2022	535	5,407	$442,908
2023	518	5,567	$524,473
2024	554	5,037	$467,269

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	183	1,724	$216,239
2016	201	1,921	$259,739
2017	246	2,344	$364,609
2018	285	2,363	$426,935
2019	319	2,399	$472,935
2020	336	2,708	$691,980
2021	435	3,043	$785,176
2022	538	4,107	$1,243,471
2023	554	4,655	$1,512,703
2024	552	4,169	$1,050,095

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	95	563	$22,908
2016	115	625	$24,584
2017	79	560	$27,932
2018	154	731	$32,362
2019	290	1,063	$55,864
2020	345	1,272	$72,934
2021	328	1,123	$48,613
2022	515	1,710	$91,519
2023	583	1,890	$96,744
2024	553	1,707	$92,080

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	87	664	$172
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	177	226	$142
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	281	560	$100
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	177	561	$97
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	166	2,282	$64

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	319	10,560	$214,234
Ofev	Nintedanib Esylate	22	660	$210,550
Breo Ellipta	Fluticasone/Vilanterol	467	15,360	$198,306
Arnuity Ellipta	Fluticasone Furoate	501	16,575	$115,484
Spiriva Respimat	Tiotropium Bromide	106	3,960	$64,657

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	35	$30,001
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	30	203	$14,394
A7030	Full face mask used with positive airway pressure device, each	N	33	80	$6,301
A7031	Face mask interface, replacement for full face mask, each	N	31	79	$6,300
E0601	Continuous positive airway pressure (cpap) device	Y	35	215	$6,018

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$873	Mylan Specialty L.P.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adel Sandouk, M.D.?

Tedicare shows public-source Medicare data for Adel Sandouk, M.D. (NPI 1043315575), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adel Sandouk, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adel Sandouk, M.D.?

Adel Sandouk, M.D. is linked to ADEL SANDOUK, M.D., INC (billing NPI 1184820961) in the available physician profile data.

Does Adel Sandouk, M.D. have Open Payments data?

Adel Sandouk, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.